These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1671525)

  • 1. Heterogeneity of immunoreactive dynorphin B-like material in human, rat, rabbit and guinea-pig heart.
    Spampinato S; Canossa M; Ventura C; Bachetti T; Venturini R; Bastagli L; Bernardi P; Ferri S
    Life Sci; 1991; 48(6):551-9. PubMed ID: 1671525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A-(1-17) and dynorphin B are released from in vitro superfused rat hypothalami. Effects of depolarizing agents and ovariectomy.
    Spampinato S; Canossa M; Bachetti T; Campana G; Murari G; Ferri S
    Brain Res; 1992 May; 580(1-2):225-32. PubMed ID: 1354557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatographic characterization of dynorphin and [Leu5]enkephalin immunoreactivity in guinea pig and rat testis.
    Cox BM; Rosenberger JG; Douglass J
    Regul Pept; 1987 Oct; 19(1-2):1-12. PubMed ID: 2891155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of immunoreactive dynorphin A in the human gastrointestinal tract.
    Spampinato S; Ferri GL; Candeletti S; Romualdi P; Cavicchini E; Soimero L; Labò G; Ferri S
    Neuropeptides; 1988 Apr; 11(3):101-5. PubMed ID: 2898739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immunoreactive dynorphin in human phaeochromocytomas.
    Howlett TA; Besser GM; Rees LH
    J Endocrinol; 1988 Apr; 117(1):123-32. PubMed ID: 2895797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive dynorphin A-like material in extracted human hypothalamic-hypophysial plasma.
    Spampinato S; Paradisi R; Canossa M; Campana G; Frank G; Flamigni C; Ferri S
    Life Sci; 1993; 52(2):223-30. PubMed ID: 8102766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin B-like immunoreactivity in gastroduodenal biopsy specimens from gallstone patients.
    Spampinato S; Speroni E; Canossa M; Sciarretta G; Malaguti P; Ferri S
    Regul Pept; 1992 Sep; 41(2):131-8. PubMed ID: 1359612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin peptides in human substantia nigra.
    Christensson-Nylander I; Terenius L
    Neuropeptides; 1985 Sep; 6(5):391-6. PubMed ID: 2865698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive dynorphin in human brain and pituitary.
    Gramsch C; Höllt V; Pasi A; Mehraein P; Herz A
    Brain Res; 1982 Feb; 233(1):65-74. PubMed ID: 6120742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corelease of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
    Knepel W; Schwaninger M; Döhler KD
    Endocrinology; 1985 Aug; 117(2):481-7. PubMed ID: 2862008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynorphin-related immunoreactive peptides in rat brain and pituitary.
    Höllt V; Haarmann I; Bovermann K; Jerlicz M; Herz A
    Neurosci Lett; 1980 Jun; 18(2):149-53. PubMed ID: 7052485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement and chromatographic characterization of prodynorphin-derived peptides in the guinea-pig ileum.
    Steele PA; Turner CA; Murphy R
    Neuropeptides; 1989 Apr; 13(3):207-13. PubMed ID: 2565558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and identification of multiple forms of dynorphin in human placenta.
    Lemaire S; Valette A; Chouinard L; Dupuis N; Day R; Porthé G; Cros J
    Neuropeptides; 1983 Jan; 3(3):181-91. PubMed ID: 16229161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of big dynorphins from rat brain and spinal cord.
    Xie GX; Goldstein A
    J Neurosci; 1987 Jul; 7(7):2049-55. PubMed ID: 2886564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a differential postnatal development of proenkephalin B (= prodynorphin)-derived opioid peptides in the rat hypothalamus.
    Seizinger BR; Grimm C; Herz A
    Endocrinology; 1984 Sep; 115(3):926-35. PubMed ID: 6547667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus.
    Chavkin C; Bakhit C; Weber E; Bloom FE
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7669-73. PubMed ID: 6143317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive dynorphin in rat tissues and plasma.
    Spampinato S; Goldstein A
    Neuropeptides; 1983 Jan; 3(3):193-212. PubMed ID: 16229162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies comparison of in vitro plasma degradation of dynorphin A 1-13.
    Müller S; Dunker R; Hochhaus G
    Pharmazie; 1996 Aug; 51(8):581-5. PubMed ID: 8794468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin-like immunoreactivity in mammalian thyroid glands: contents and partial characterization.
    Oyama H; Kameda Y; Endoh M; Nagase Y; Matsuki M; Kakita K; Tenku A; Nishida S; Horino M
    Endocrinology; 1984 Mar; 114(3):1028-32. PubMed ID: 6141931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The posttranslational processing of prodynorphin in the rat anterior pituitary.
    Day R; Akil H
    Endocrinology; 1989 May; 124(5):2392-405. PubMed ID: 2651096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.